Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Latest filing published 10 Jun 2026 for Intellia Therapeutics, Inc.. Read the official filing
Filing timeline
BuySaleBrian Goff
Insider track record
Disclosed buys
0
Disclosed sells
10
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Brian Goff: trading record in brief
Brian Goff (senior executive) discloses dealings in 3 companies, chiefly Agios Pharmaceuticals, Inc., Alexion Pharmaceuticals Inc and Intellia Therapeutics, Inc. We count 33 filings; the first trade dates from 8 June 2021 and the latest from 9 June 2026.
No open-market purchase appears, only 10 sales worth €2.2M. Besides market trades, the filings include 5 share grants and 17 option exercises. Since January 2026: no purchases and 5 sales on the market.
The newest entry dates from 10 June 2026: a share grant, in Intellia Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Brian Goff
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations33 total
9,200 sharesCommon StockSEC:0001193125-26-266236:0
25,528 shares0Common stockSEC:0001439222-26-000057:0
13,500 shares0Common stockSEC:0001439222-26-000057:2
12,472 shares@ US$34.7165.4% of flowCommon stockSEC:0001439222-26-000057:1
6,596 shares@ US$34.7134.6% of flowCommon stockSEC:0001439222-26-000057:3
3,870 shares@ US$28.965.9% of flowCommon stockSEC:0001439222-26-000044:1
8,267 shares@ US$28.9612.6% of flowCommon stockSEC:0001439222-26-000044:3
5,918 shares@ US$28.969.0% of flowCommon stockSEC:0001439222-26-000044:5
8,500 shares0Common stockSEC:0001439222-26-000044:0
18,000 shares0Common stockSEC:0001439222-26-000044:2
13,000 shares0Common stockSEC:0001439222-26-000044:4
25,528 shares0Common stockSEC:0001439222-26-000008:0
11,085 shares@ US$36.6721.6% of flowCommon stockSEC:0001439222-25-000093:1
22,691 shares0Common stockSEC:0001439222-25-000093:0
25,527 shares0Common stockSEC:0001439222-25-000063:0
8,000 shares0Common StockSEC:0000950170-25-086271:0
4,153 shares@ US$35.548.8% of flowCommon stockSEC:0001439222-25-000015:1
8,794 shares@ US$35.5418.6% of flowCommon stockSEC:0001439222-25-000015:3
8,500 shares0Common stockSEC:0001439222-25-000015:0
18,000 shares0Common stockSEC:0001439222-25-000015:2
22,691 shares0Common stockSEC:0001439222-24-000123:0
15,409 shares0Common StockSEC:0000950170-24-074383:0
25,527 shares0Common stockSEC:0001439222-24-000073:0
4,156 shares@ US$32.577.7% of flowCommon stockSEC:0001439222-24-000048:1
8,500 shares0Common stockSEC:0001439222-24-000048:0
25 of 33 declarations
